NCT00005832 - S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

Pancreatic Cancer

Interventions

DRUG

R115777

300mg/dose BID, PO, Days 1-21, q 28days

Trial Locations (14)

29303

CCOP - Upstate Carolina, Spartanburg

29615

CCOP - Greenville, Greenville

43206

CCOP - Columbus, Columbus

59101

CCOP - Montana Cancer Consortium, Billings

62526

CCOP - Central Illinois, Decatur

64131

CCOP - Kansas City, Kansas City

67218

Veterans Affairs Medical Center - Wichita, Wichita

94553

Veterans Affairs Outpatient Clinic - Martinez, Martinez

95817

University of California Davis Medical Center, Sacramento

98101

CCOP - Virginia Mason Research Center, Seattle

90033-0800

USC/Norris Comprehensive Cancer Center, Los Angeles

67214-3882

CCOP - Wichita, Wichita

77555-0209

University of Texas Medical Branch, Galveston

98405-0986

CCOP - Northwest, Tacoma

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK